Automation index

How much of a Hearing aid technician’s job can AI already do?

An earmould and a gain curve come earlier. Getting the patient to hear and live with it do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

24%

AI can already do 24% of this job.

#281 / 633

Hearing aid technician

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Audiometry, thresholds and the fitting. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Take the mould, trial and the one who hates the whistle. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Program, verify and retune the aid. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Repair, batteries and aftercare. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Explain, family and the stigma of the device. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
That they actually hear, and not taking the aid back. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		24%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 633

Nuclear medicine physician

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
PET, SPECT protocols and a stock report. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
Order dose, timing and preparation. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Give the isotope and watch the reaction. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Clinic, the cancer that returns and the family. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Quality, waste and radiation protection. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Signing the study and the dose you cannot repeat. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low